Gossamer Bio (GOSS) Short term Debt (2022 - 2024)
Historic Short term Debt for Gossamer Bio (GOSS) over the last 3 years, with Q1 2024 value amounting to $9.6 million.
- Gossamer Bio's Short term Debt fell 1742.87% to $9.6 million in Q1 2024 from the same period last year, while for Mar 2024 it was $9.6 million, marking a year-over-year decrease of 1742.87%. This contributed to the annual value of $11.6 million for FY2023, which is 0.0% changed from last year.
- Latest data reveals that Gossamer Bio reported Short term Debt of $9.6 million as of Q1 2024, which was down 1742.87% from $11.6 million recorded in Q4 2023.
- Gossamer Bio's Short term Debt's 5-year high stood at $11.6 million during Q4 2022, with a 5-year trough of $9.6 million in Q1 2024.
- Moreover, its 3-year median value for Short term Debt was $11.6 million (2022), whereas its average is $11.3 million.
- As far as peak fluctuations go, Gossamer Bio's Short term Debt changed by 0.0% in 2023, and later crashed by 1742.87% in 2024.
- Quarter analysis of 3 years shows Gossamer Bio's Short term Debt stood at $11.6 million in 2022, then changed by 0.0% to $11.6 million in 2023, then decreased by 17.43% to $9.6 million in 2024.
- Its last three reported values are $9.6 million in Q1 2024, $11.6 million for Q4 2023, and $11.6 million during Q3 2023.